Velocity Composites
VEL · AIM · Industrial Goods and Services · mcap £8.9m · 16.2p
Velocity Composites cuts and packs composite materials into ready-to-use kits for aircraft makers, mainly for Airbus A350 wings, military programmes and US engine work. It operates from the UK and a US facility.
| Date | Type | Announcement | Day |
|---|---|---|---|
| 23 Jul 26 | Board change | Appointment of Chief Financial Officer
Matthew Fowler appointed Group CFO from 1 September 2026, replacing retiring Rob Smith. |
+0.0% |
| 24 Jun 26 | Results | Half-year Results
H1 revenue fell 19% to £8.4m; adjusted EBITDA halved to £0.1m; FY guidance cut to £0.5m. |
−11.7% |
|
below current market expectations expectations Revenue £8.4m (£10.4m)Gross margin 28.0% (29.0%)Adjusted EBITDA £0.1m (£0.3m)Loss before tax £1.0m (£0.6m)Cash at bank £0.7m (£0.4m)Net cash position £0.5m (net debt £0.1m)
|
|||
| 18 Jun 26 | Notice of Investor Presentation
Company to publish interim results on 24 June 2026 and hold investor presentation on 25 June 2026. |
+0.0% | |
| 26 May 26 | Trading update | Trading Statement
H1 26 revenue £8.4m down from £10.4m; adjusted EBITDA £0.1m; balance sheet improved to net cash £0.4m. |
+9.4% |
|
Revenue H1 26 £8.4m (£10.4m)Adjusted EBITDA H1 26 £0.1m (£0.3m)Net cash at 30 April 2026 £0.4m (net debt £0.1m)Cash at bank at 30 April 2026 £0.6m (£0.4m)CBIL loan balance £0.2m (£0.5m)Undrawn invoice discounting facility £3m
|
|||
| 23 Apr 26 | Board change | Directorate Change
CFO Rob Smith to retire from board by 31 October 2026, continuing until end of financial year. |
+2.0% |
| 23 Mar 26 | Grant of Share Options to Directors/PDMRs
Board granted 1.36m share options to directors and management at 12.56p exercise price. |
+0.0% | |
| 09 Feb 26 | Change of Joint Broker
Singer Capital Markets appointed as joint corporate broker following Dowgate Capital team transfer. |
−2.9% | |
| 27 Jan 26 | Results | Replacement - Audited Final Results
Revenue £20.7m in line with guidance; adjusted EBITDA doubled to £1.0m but cash fell and customer production shifted. |
−5.3% |
|
in line expectations Revenue £20.7m (£23.0m)Adjusted EBITDA £1.0m (£0.4m)Gross margin 29.5% (25.9%)Cash at bank £0.4m (£1.7m)Net debt £0.1m (£0.7m net cash)
|
|||
| 27 Jan 26 | Results | Final Results
Revenue down to £20.7m but adjusted EBITDA doubled to £1.0m; gross margin improved to 29.5%. |
−5.3% |
|
in line expectations Revenue £20.7m (£23.0m)Gross margin 29.5% (25.9%)Adjusted EBITDA £1.0m (£0.4m)Cash at bank £0.4m (£1.7m)Net debt £0.1m (£0.7m net cash)Administrative expenses £6.9m (£7.0m)
|
|||
| 13 Jan 26 | Notice of Investor Presentation - Replacement
Correction to investor presentation date: presentation scheduled for 28 January 2026 at 10:00am. |
+0.0% | |
| 08 Jan 26 | Notice of Investor Presentation
Company to publish FY2025 results on 27 January 2026 and hold investor presentation on 28 January. |
+0.0% | |
| 27 Nov 25 | Director dealing | PDMR/Director shareholding
Emma Bridges, wife of CEO Jon Bridges, sold 333,333 shares at 15p per share. |
−4.4% |
| 25 Nov 25 | Grant of Share Options to Directors/PDMRs
Board granted 1,049,139 share options to directors and PDMRs in lieu of 20% salary sacrifice. |
+0.0% | |
| 05 Nov 25 | Trading update | Trading Update
FY25 revenue £20.7m down 10% due to lower A350 production rates and US programme delays; adjusted EBITDA more than doubles. |
−16.4% |
|
below expectations Revenue £20.7m (£23.0m)Adjusted EBITDA more than double FY24 (£0.4m)Gross cash balance £0.4m (£1.6m)Net cash £nil (£0.7m)Invoice discounting facility £3m unutilised
|
|||
| 08 Oct 25 | Contract Renewal and Expansion
10-year contract extension and expansion with Tier One customer for A350 composite kits through 2035. |
+4.4% | |
|
Expected FY26 revenue $2.5 millionNew business in FY26 $1.0 millionTotal contract value potential $54 millionContract duration 10 years to 2035
|
|||
| 08 Jul 25 | Exercise of Share Options and Issue of Equity
Chief Commercial & Compliance Officer Matthew Archer exercised 604,167 share options at 0.25p and sold 287,602 shares to cover tax. |
−1.8% | |
| 25 Jun 25 | Results | Unaudited Half Year Results
H1 FY25 revenue flat at £10.4m, but gross margin expanded to 29.0% and adjusted EBITDA turned positive at £0.3m. |
+5.0% |
|
in line with current market expectations expectations Revenue £10.4m (£10.7m)Gross margin 29.0% (22.5%)Adjusted EBITDA £0.3m (£0.2m loss)Pre-tax loss £0.6m (£1.1m)Cash at bank £1.2m (£1.8m)Net cash £0.4m (£0.6m)
|
|||
| 29 May 25 | Notice of Investor Presentation
Company confirms interim results publication date and investor presentation scheduled for 25 June 2025. |
+5.4% | |
| 22 May 25 | Trading Update & Notice of Results
H1 25 revenue flat at £10.4m but adjusted EBITDA turned positive for first time since pre-pandemic. |
−12.9% | |
|
Revenue lower than expected due to customer production rates expectations Revenue £10.4m (£10.7m)Adjusted EBITDA £0.3m (£(0.2)m loss)Cash at bank £1.2m (£1.8m)Undrawn invoice discount facility £3.0m
|
|||
| 14 May 25 | Exercise of Share Options and Issue of Equity
Staff member exercised 17,338 share options at 0.25 pence per share. |
+0.0% | |
| 12 May 25 | Renewal of BAE Systems Contract
Velocity Composites renews three-year contract with BAE Systems with price increase included. |
+10.6% | |
|
in line with FY25 revenue expectations expectations Contract duration three years
|
|||
| 29 Apr 25 | Exercise of Share Options and Issue of Equity
Employee exercised 37,500 share options at 0.25 pence per share, increasing total shares in issue. |
+0.0% | |
| 28 Mar 25 | Exercise of Share Options and Issue of Equity
Employee exercised 17,000 share options at 0.24p per share. |
+0.0% | |
| 04 Feb 25 | Appointment of Chief Operations Officer
Oliver Smalley appointed Chief Operations Officer to drive operational improvements and capture growth opportunities in US and Europe. |
+0.0% | |
| 03 Feb 25 | Grant of Share Options
Board granted 2.09 million share options to directors and management team on 31 January 2025. |
−1.6% | |
| 29 Jan 25 | Results | Audited Final Results to 31 October 2024
Revenue grew 40% to £23.0m and achieved adjusted EBITDA profit of £0.4m in FY24. |
+12.3% |
|
Revenue £23.0m (£16.4m)Gross margin 25.9% (18.8%)Adjusted EBITDA £0.4m (£(1.6)m)US revenue £7.9m (£2.0m)Net cash position £0.7m (£1.6m)
|
|||
| 15 Jan 25 | Notice of Investor Presentation
Company announced publication of full year results and live investor presentation scheduled. |
+3.6% | |
| 20 Dec 24 | Exercise of Share Options and Issue of Equity
Directors exercised 483,660 share options at 0.25p; new shares admitted to AIM on 24 December 2024. |
−6.3% | |
| 12 Dec 24 | Trading Update & Notice of Results
Revenue up 40% to £23.0m with first positive adjusted EBITDA since pandemic; US sales quadrupled. |
+17.7% | |
|
slightly ahead of current market forecasts expectations Revenue £23.0m (£16.4m)Adjusted EBITDA £0.4m (£(1.6m) loss)US sales £7.9m (£2.0m)Gross cash £1.7m (£3.2m)Net cash £0.7m (£1.6m)Cash inflow from operations £0.4m (£(1.8m) outflow)
|
|||
| 26 Sep 24 | Exercise of Share Options and Issue of Equity
41,338 share options exercised at 0.25p per share; 41,338 new ordinary shares to be admitted to AIM. |
+0.0% | |
| 18 Sep 24 | Trading update | Trading Update
FY24 revenue expected at £22.8m, up 40% year-on-year, with positive EBITDA, but short-term delays to US and UK programmes. |
−8.0% |
|
below expectations FY24 Revenue guidance not less than £22.8m (£16.4m (FY23))FY24 Adjusted EBITDA not less than approximately £0.3m (loss of £1.6m (FY23))Revenue growth approximately 40%A350 contract renewal until at least 28 February 2026 (from 1 September 2024)
|
|||
| 17 Jul 24 | Grant of Share Options
Board and management granted 1.6 million share options at 41.5p exercise price, vesting subject to EBITDA targets. |
+0.4% | |
|
Total share options granted 1,600,000Exercise price per share 41.5pDirectors granted options 4Management team options 800,000Total options outstanding after grant 3,299,365Options as % of issued capital 6.2%
|
|||
| 09 Jul 24 | Results | Half-year Results
Revenue up 54% to £10.7m; company on track for H2 profitability and cash generation with US facility ramping up. |
+9.2% |
|
in line expectations Revenue £10.7m (£7.0m)Gross margin 22.5% (21.8%)EBITDA loss £0.2m (£0.9m loss)Loss before tax £1.1m (£1.4m loss)Cash at bank £1.8m (£1.2m)Net cash £0.6m (£1.7m net debt)
|
|||
| 21 Jun 24 | Notice of Investor Presentation
Interim results for six months to 30 April 2024 to be published 9 July 2024 with investor presentation. |
+0.0% | |
| 22 May 24 | Trading Update & Notice of Results
H1 FY24 revenue grew 53% to £10.7m; EBITDA loss narrowed to £0.2m; FAI progress enables 90% of FY24 US contract revenue. |
−1.2% | |
|
in line with management forecasts expectations H1 FY24 Revenue £10.7m (£7.0m)H1 FY24 EBITDA loss of £0.2m (loss of £0.9m)Cash at bank £1.8m (£1.2m)Net cash/(debt) £0.6m (net debt of £1.8m)US Contract revenue over 5 years £79mQualified pipeline £200m
|
|||
| 02 May 24 | Change of Nominated Adviser and Corporate Broker
Appointed Canaccord Genuity as Nominated Adviser and Joint Corporate Broker alongside Dowgate Capital. |
+4.8% | |
| 11 Mar 24 | Board change | Appointment of Chief Financial Officer
Robert Smith appointed Group Chief Financial Officer and Company Secretary, effective 3 June 2024. |
+4.4% |
| 11 Mar 24 | Update on US Contract and OEM Approvals
GE Aerospace approves final block of US contract; expects FAI completion by end April 2024, on track for FY2024 forecasts. |
+4.4% | |
|
in line expectations US Contract annual revenue $20m per annumContract duration at least five years (from 1 January 2024)Completed blocks at FY2023 end two of four (over 50% of annual contract value)Expected FY2025 revenue from final block 39% of full year US revenue
|
|||
| 13 Feb 24 | Appointment of Dowgate Capital as Joint Broker
Dowgate Capital appointed as joint broker with immediate effect. |
+0.0% | |
| 24 Jan 24 | Grant of Share Options & Issue of Equity
Board granted 357,134 share options to Directors and PDMRs; former employee exercised 75,000 options at 35.5p. |
+1.4% | |
| 23 Jan 24 | Results | Final Results
Revenue grew 37% to £16.4m but EBITDA loss widened to £1.6m due to US facility startup costs. |
+2.9% |
|
in line expectations Revenue £16.4m (£12.0m)Adjusted EBITDA loss of £1.6m (loss of £0.5m)Gross margin 18.8% (23.0%)Net cash position £1.6m (£0.2m)US facility maiden revenue £2.0m (nil)GKN Aerospace contract value US$20m per annum
|
|||
Company filings. Not investment advice.